CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
D700 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02878213
NCT02878213N/ACompleted

DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness

EPD Solutions, A Philips Company·interventional·Posted Aug 25, 2016·Updated Nov 18, 2019

In Brief

A clinical study evaluating D700 System for Atrial Fibrillation. Completed, enrolled 39 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate real-time gap detection using EPD D700 dielectric sensing compared with customary electrical isolation tests and Adenosine infusion at the end of the procedure. Furthermore, safety, usability and clinical applicability of the system for guided AF ablation will be confirmed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 25, 2016
Enrollment StartSep 23, 2016
Primary CompletionJan 25, 2017
Study CompletionNov 16, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.9 years ago

Interventions

D700 Systemdevice

Atrial Fibrillation Ablation Procedure